Authors
Latest:
What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental CountermeasuresHow has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?
Latest:
A Case of Chronic Granulomatous Mastitis Caused by Corynebacterium kroppenstedtiiA full case study from our August 2020 issue.
Latest:
An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted ScabiesA patient with HIV and skin lesions should trigger a broad differential.
Latest:
Current and Potential Treatment Options for Stenotrophomonas maltophilia InfectionsWe review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
Latest:
An Unusual Case of Testicular Swelling in a Patient With HIVBeing immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
Latest:
Community Acquired Pneumonia and the Role of Adjunctive CorticosteroidsAntibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.
Latest:
Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant RecipientExpanding the differential for diarrhea beyond Clostridium difficile.
Latest:
Evidence-Based Intervention Reduces C. diff Rates in Adults With CancerSMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
Latest:
Are Two Antibiotics Better Than One?A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
Latest:
The Ripple Effect of Climate Change on Epidemic RiskWhile rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
A Case of Disseminated Nocardia farcinica Presenting as Fever of Unknown Origin in a Transplant PatientOutcomes in disseminated nocardiosis are variable and depend on patient factors.
Latest:
Four Fungal Horsemen: Emerging Trends in Fungal Disease EpidemiologyNew public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Latest:
Long-Acting Anti-MRSA Agents: One Dose to Cure?A review of the current literature and future directions.
Latest:
New Technology Enables Differentiation of Bacterial and Viral InfectionsIt can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.
Latest:
Living and Aging With HIV: Recognition and Management of Common Prescribing PitfallsWith advancements in antiretroviral therapy, people with HIV are now living longer and developing age-related chronic conditions.
Latest:
An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted ScabiesA patient with HIV and skin lesions should trigger a broad differential.
Latest:
With the Opioid Epidemic, Communities See Dramatic Increases in Infectious DiseasesRising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.
Latest:
Intravenous Antimicrobials: Is It Time to Push?Intravenous (IV) push is an attractive option to administer antimicrobial therapy to patients in an efficient and effective manner in a variety of clinical settings. While many advantages to IV push administration exist, clinicians should be mindful of available literature regarding safety profiles, pharmacokinetic/pharmacodynamic characteristics, and clinical data for IV push antimicrobial administration prior to utilizing it in specific patient populations.
Latest:
New and Pipeline Antiretroviral Agents for the Treatment of HIV-1 InfectionThis article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
Latest:
Will Brazil's Next Epidemic Come from Another Mosquito-Borne Virus?As researchers discover Chikungunya-carrying mosquitoes in Brazil, a new study analyzes the impact of the Zika virus on the area.
Latest:
Using IL-6 Inhibitors to Treat COVID-19Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.
Latest:
Clinicians Only Using New Antibiotics in Quarter of CRE Infection Cases, New Study FindsAs a growing number of infections become resistant to antibiotic medications, it is becoming crucially important that providers not only practice antibiotic stewardship but also use effective antibiotics when they are needed.
Latest:
Four Fungal Horsemen: Emerging Trends in Fungal Disease EpidemiologyNew public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Latest:
What the 2018 DRC Ebola Epidemic Taught Us About Outbreak Response and Experimental CountermeasuresHow has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?
Latest:
A Peculiar Finding in an Unfamiliar PatientA rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.
Latest:
Successful Stewardship Strategies in Long-Term Care FacilitiesOne successful model takes an engineering approach to patient safety outcomes focusing on work system improvements.
